Acute Mesenteric Ischemia

Enabling early and accurate diagnosis of Acute Mesenteric Ischemia (AMI)

Acute Mesenteric Ischemia is a hard-to-detect and deadly condition. Every 30 minutes of delay in emergency room diagnosis increases the mortality rate from AMI by about 5%, and the medical community has been calling for a rapid diagnostics solution to AMI for the last 30+ years.

Our team has designed and validated a biomarker for blood tests that allows early diagnosis.

In collaboration with our medical partners, we have developed a magnetic bead-based assay to validate a novel biomarker for blood tests that allow early diagnosis of Acute Mesenteric Ischemia.

We are developing a screening test based on this biomarker which enables rapid diagnosis of Acute Mesenteric Ischemia. We anticipate a mortality rate reduction from our test of up to 75% and we think we can savings of >$6bil annually to IDNs and healthcare providers in our core markets (which are the USA and Western Europe).